Evotec SE (OTCMKTS:EVTCY - Get Free Report) shares passed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $3.78 and traded as high as $4.05. Evotec shares last traded at $3.97, with a volume of 392,937 shares traded.
Evotec Price Performance
The firm has a market cap of $1.33 billion, a price-to-earnings ratio of 9.83 and a beta of 0.98. The business has a 50 day simple moving average of $3.79 and a 200-day simple moving average of $4.16. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.50 and a current ratio of 2.57.
Evotec Company Profile
(
Get Free Report)
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Read More
Before you consider Evotec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evotec wasn't on the list.
While Evotec currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
